With Biohit Calprotectin ELISA, the determination between inflammatory bowel diseases (IBD) and irritable bowel syndrome (IBS) can be made non-invasively and in-expensively from a stool sample. In organic disorders like IBD, the concentration fecal calprotectin increases significantly, whereas with functional disorders like IBS this does not occur.
Biohit Calprotectin ELISA can also be used for monitoring the mucosal healing of a patient with IBD. This for example helps to support the practitioner in making informed decisions concerning medication and the need for medical procedures such as endoscopy or surgery.
Applications
Differentiates Inflammatory bowel diseases (IBD) from Irritable bowel syndrome (IBS)
Monitoring of mucosal healing with IBD patients
Relapse prediction (clinical remission)
Sampling made easy
Consistence of the feces does not affect the result
Only a small amount of sample required
Easy handling with hygienic extraction tubes = reduced process time
Straightforward analysis
Wide assay range with only one dilution 25 – 2500 mg/kg in feces
Fits directly into automated systems (e.g. Dynex DS2)
Validated results from a proven assay
Use of Biohit Extraction Tubes (Cat. No. 602 270) is highly recommended for optimal analytical performance.
Notice:
Availability limited in some countries. Please contact us for more details: info (at) biohit.fi.
In the USA and Japan, for research use only. For other countries, please check with your local Biohit distributor.
Biohit Calprotectin ELISA is a quantitative test which provides a reliable differentiation between inflammatory bowel diseases (IBD) and irritable bowel syndrome (IBS).